This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rite Aid, CVS Post Solid Sales

Consumers continue to spend, at least at the drugstore.

The nation's largest drugstore chains have reported solid July sales numbers, in sharp contrast to other recent data such as earnings warnings from apparel companies and flagging consumer confidence that suggest consumers may finally be tapped out.

On Tuesday, CVS (CVS - Get Report) and Rite Aid (RAD - Get Report), the nation's second- and third-largest drugstore chains, reported hefty gains in same-store sales numbers for July, igniting a mild rally in their shares.

CVS said that same-store sales, which measure activity in shops open at least a year, rose 9% in July, while Rite Aid said its comparable store sales rose 7.4%. On Friday, Walgreen (WAG), the nation's largest drugstore chain, reported an 11% gain in same-store sales.

In early trading Tuesday, Rite Aid was up 6 cents, or 3%, at $2.07; CVS gained $1.16, or 4.4%, to trade at $27.61; and Walgreen was up 88 cents at $33.50.

The news from the drugstore chains was much brighter than other recent retail indicators. A number of earnings warnings lately, from apparel chains Hot Topic (HOTT), Wet Seal (WTSLA)and Children's Place (PLCE), have hammered the sector, just as most major retailers prepare to report July sales on Thursday. At the same time, the latest consumer confidence figures showed a decline of 9 points in July compared with June, fanning fears that the consumer's resilience, which has helped to keep the economy afloat as business investment tanked, may be waning.

Still, even drugstore stocks -- long thought to be recession-proof -- have not held up well during the downturn. All three of the largest chains have had their own problems. Rite Aid stock has lost more than half its value this year as investors became leery of the company's turnaround hopes. The company was forced to restate earnings in 2000 after a wide-ranging accounting probe, and earlier this year it reported that its losses were larger than anticipated.

Meanwhile, CVS and Walgreen shares are off slightly on the year -- a better performance than the major averages, but investors have lost money nonetheless. CVS has been hampered by a pharmacy shortage, while investors have come to worry about Walgreen's pricey valuation and stepped-up competition from mass merchandisers.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CVS $95.45 1.45%
DRD $1.51 -0.66%
RAD $7.89 0.13%
WAG $81.65 2.05%
AAPL $117.34 -0.81%


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs